Rebecca Schaffer is a Senior Scientist in In Vivo Pharmacology at Eli Lilly, where they focus on innovative genetic therapies for prevalent diseases. They possess over 5 years of experience in academic and industry research, specializing in neurodegenerative disorders and skilled in various methodologies including molecular biology and microscopy. Rebecca previously worked as a Research Assistant at Harvard University, an Associate Scientist II at Atalanta Therapeutics, and completed a research fellowship at SUNY Downstate Medical Center. They earned a degree in Neuroscience, Neurobiology and Behavior from Smith College in 2019.
This person is not in the org chart
This person is not in any teams
This person is not in any offices